These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10188756)

  • 1. Treatment of sepsis: past and future avenues.
    Baumgartner JD; Calandra T
    Drugs; 1999 Feb; 57(2):127-32. PubMed ID: 10188756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in prevention and treatment of severe sepsis and septic shock.
    Kouroumichakis I; Papanas N; Proikaki S; Zarogoulidis P; Maltezos E
    Eur J Intern Med; 2011 Apr; 22(2):125-33. PubMed ID: 21402241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis.
    Lv S; Han M; Yi R; Kwon S; Dai C; Wang R
    Int J Clin Pract; 2014 Apr; 68(4):520-8. PubMed ID: 24548627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis: time to reconsider the concept.
    Carlet J; Cohen J; Calandra T; Opal SM; Masur H
    Crit Care Med; 2008 Mar; 36(3):964-6. PubMed ID: 18431286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine modulation in sepsis and septic shock.
    Zanotti S; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1061-75. PubMed ID: 12150702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and emerging therapies for sepsis and septic shock.
    Añel RL; Kumar A
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1471-85. PubMed ID: 11772263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, vitamin D, and severe sepsis.
    Mascitelli L; Grant WB; Goldstein MR
    Eur J Intern Med; 2011 Aug; 22(4):e25-6; author reply e27. PubMed ID: 21767742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent clinical trials for sepsis: analysis of the results and future perspectives].
    Wakabayashi G; Shimazu M; Tanabe M; Ueda M; Hoshino K; Morikawa Y; Kitajima M
    Nihon Geka Gakkai Zasshi; 1999 Oct; 100(10):674-8. PubMed ID: 10570778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.
    Vazquez-Grande G; Kumar A
    Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and sepsis.
    Gao F; Linhartova L; Johnston AM; Thickett DR
    Br J Anaesth; 2008 Mar; 100(3):288-98. PubMed ID: 18276651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the treatment of sepsis.
    Sharma VK; Dellinger RP
    Expert Opin Investig Drugs; 2003 Feb; 12(2):139-52. PubMed ID: 12556210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock.
    Aikawa N; Takahashi T; Fujimi S; Yokoyama T; Yoshihara K; Ikeda T; Sadamitsu D; Momozawa M; Maruyama T
    J Infect Chemother; 2013 Oct; 19(5):931-40. PubMed ID: 23681364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.